(1888PressRelease)
June 24, 2009 - Used in the management of Over Active Bladder (OAB), Bispec™ is the best-in-class for OAB and has lesser incidence of dry mouth and constipation.
People suffering from OAB have a warning time of about 12 seconds. Solifencin Succinate helps increase the warning time to about 32 seconds.
Bispec™ is available in tablet form, and in dosages of 5 mg and 10 mg.
Notes to the Editor:
The market size for products used in the treatment of OAB is about Rs 194 million growing at 7% ( source ORG MAT April 2009)
Brief mode of action of Bispec™:
Solifencin acts by competitively inhibiting Acetyl choline from binding to cholinergic receptors present in bladder.
This reduces bladder contractions and improves warning time in over active bladder patients.
Solifencin Succinate is highly receptor (M3) specific and has superior pharmacokinetic profile
Other leading brand of Dr. Reddy’s in this segment is TORQ.
Warning Time: Period between first sensation of urgency and urination in patients with OAB syndrome
Globally June 22 – 28 is celebrated as the World Continence Week
About Dr. Reddy’s
Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company. We fulfill our purpose of providing affordable and innovative medicines through three core businesses: Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Our products are marketed globally, with a focus on India, US, UK, Germany and Russia. www.drreddys.com
Contact Information
Investors and Financial Analysts:
Kedar Upadhye at kedaru ( @ ) drreddys dot com /+91-40-66834297 | Raghavender R at raghavenderr ( @ ) drreddys dot com /+91-40-66511529 | Milan Kalawadia (North America) at mkalawadia ( @ ) drreddys dot com or at 908-203-4931
Media
Mythili M at mythilim ( @ ) drreddys dot com or on +91-40-66511620
Rajan S at rajans ( @ ) drreddys dot com / +91-40- 66511725
http://www.drreddys.com
###
